- Home
- ZDGE vs ANTX Comparison
ZDGE vs ANTX Comparison
Compare ZDGE & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZDGE
- ANTX
- Stock Information
- Founded
- ZDGE 2008
- ANTX 2017
- Country
- ZDGE United States
- ANTX United States
- Employees
- ZDGE N/A
- ANTX N/A
- Industry
- ZDGE Computer Software: Prepackaged Software
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- ZDGE Technology
- ANTX Health Care
- Exchange
- ZDGE Nasdaq
- ANTX Nasdaq
- Market Cap
- ZDGE 40.3M
- ANTX 37.3M
- IPO Year
- ZDGE N/A
- ANTX 2022
- Fundamental
- Price
- ZDGE $2.33
- ANTX $1.17
- Analyst Decision
- ZDGE
- ANTX Buy
- Analyst Count
- ZDGE 0
- ANTX 4
- Target Price
- ZDGE N/A
- ANTX $2.00
- AVG Volume (30 Days)
- ZDGE 35.5K
- ANTX 135.8K
- Earning Date
- ZDGE 06-09-2025
- ANTX 05-23-2025
- Dividend Yield
- ZDGE N/A
- ANTX N/A
- EPS Growth
- ZDGE N/A
- ANTX N/A
- EPS
- ZDGE N/A
- ANTX N/A
- Revenue
- ZDGE $29,412,000.00
- ANTX N/A
- Revenue This Year
- ZDGE N/A
- ANTX N/A
- Revenue Next Year
- ZDGE $1.07
- ANTX N/A
- P/E Ratio
- ZDGE N/A
- ANTX N/A
- Revenue Growth
- ZDGE 4.26
- ANTX N/A
- 52 Week Low
- ZDGE $1.73
- ANTX $0.87
- 52 Week High
- ZDGE $4.38
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- ZDGE 51.61
- ANTX 39.43
- Support Level
- ZDGE $2.31
- ANTX $1.16
- Resistance Level
- ZDGE $2.53
- ANTX $1.29
- Average True Range (ATR)
- ZDGE 0.17
- ANTX 0.06
- MACD
- ZDGE -0.00
- ANTX -0.00
- Stochastic Oscillator
- ZDGE 21.95
- ANTX 45.83
About ZDGE Zedge Inc. Class B
Zedge Inc provides content distribution platforms. Its content platform enables consumers to personalize their mobile devices with free, high-quality ringtones, wallpapers, home screen app icons, widgets and notification sounds as well as paint, a generative AI wallpaper maker, GuruShots, a skill-based photo challenge game, and Emojipedia. The company also launched a Zedge app. It has two reportable segments, which are the Zedge Marketplace and GuruShots.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.